This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USA
Tickets
Menu
Tickets
Key Sessions
Jessica Federer
Investing in Biotech Breakthroughs: A VC Outlook
Angelini Ventures
Mary Schaheen
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
Prevail Partners LLC
Lei Meng
Series A Secured, What's Next? Scaling Your Biotech
Bain Capital Life Sciences
Scott DeWire
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
Boehringer Ingelheim
Marian Nakada
Funding Biotech Innovation: The CVC Perspective
JJDC
Mike Patten
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
Harbour BioMed
Joe Heanue
Medtech’s Next Big Thing: Where the Big Players Are Placing Their Focus
Triple Ring Technologies
Wayne Jarvis
Mapping the Medtech M&A Landscape: Strategies for Companies in a Changing Market
Coloplast
keyboard_arrow_right

Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
8:00am - 8:15am
Breakfast & Registration (8:00-9:00am)
8:15am - 8:55am
First Timer Orientation

Join us in the Exhibition and Catering Hall – Connection Hub (Room 258A-C) for a special welcome breakfast exclusively for first-time attendees!

During this session, our team will:

  • Provide an overview of the event
  • Share tips to maximize your experience
  • Help you navigate the schedule and venue
  • Answer any questions you may have

BONUS: The first 100 attendees will receive a complimentary welcome tote bag filled with essentials to enhance your week at the event.

Showing 4 of 4 Streams
8:55am - 9:00am
LSX Welcome Address
9:00am - 9:50am
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
  • Mary Schaheen - President, Prevail Partners LLC
  • Michael Cohen - Partner, Brown Rudnick
  • Bibhash Mukhopadhyay - CEO, Sapient Biotech Investments & Chief Investment Adviser, Miletus Biotechnology
  • Geeta Vemuri - Founder & Managing Partner, Agent Capital
9:50am - 10:30am
Impact of AI on the Future of the Pharmaceutical Industry
  • Patricia Bradley - Global CCO, MindMaze
8:55am - 9:00am
Obesity Science & Innovation Welcome
9:00am - 9:10am
Keynote Opening Address
  • Jacob Peterson - SVP Head of Diabetes, Obesity & MASH Therapy, Novo Nordisk
9:10am - 9:50am
Keynote Panel: Pipeline Priorities – Exploring Leading and Emerging Targets Shaping the Future of Obesity Therapeutics
  • Vipin Garg - CEO, Altimmune
  • Karen Wurster - CEO, Adipo Tx
  • Punit Dhillon - CEO, Skye Bioscience
  • Riccardo Panella - CSO & Scientific Founder, Resalis Therapeutics
9:50am - 10:30am
Keynote Panel: Crafting Industry Collaborations – The Pharma Perspective
  • Jacob Peterson - SVP Head of Diabetes, Obesity & MASH Therapy, Novo Nordisk
  • Daniel Markgraf - Head of Laboratory, Cardio-Renal-Metabolic Disease Research, Boehringer Ingleheim
  • Jovita Marcinkeviciene - Executive Director, Cardiovascular & Metabolism, Novartis Biomedical Research
  • Alice Gilman - COO, R3 Biotechnologies
8:55am - 9:05am
LSX Welcome Address
9:05am - 9:50am
Medtech’s Next Big Thing: Where the Big Players Are Placing Their Focus
  • Joe Heanue - CEO, Triple Ring Technologies
  • Denise Clarke - Director, Strategy & Business Development, Philips Healthcare
  • Len Usvyat - Head of Renal Research Institute, SVP, Fresenius Medical Care
  • Donny Patel - President, Connected Care, Baxter
  • Ryan Hess - Senior Director, Strategy and Innovation, Ricoh USA
  • Rachel Ford Hutman - Founcer & CEO, Ford Hutman Media
9:50am - 10:30am
Mapping the Medtech M&A Landscape: Strategies for Companies in a Changing Market
  • Wayne Jarvis - Senior Director BD & Portfolio Strategy, Coloplast
  • Sonal Patel - Vice President, Business Development Strategy & Ventures, Zimmer Biomet
  • Kevin Rocco - Founder, Biorez
  • Kristin King-Jankiewicz - Head of Group Management, Boston Harbor Angels
8:55am - 9:05am
LSX Welcome Address
9:05am - 9:45am
AI & Pharma – Operationalising AI for Enhanced Patient and Commercial Benefits
  • Emre Ozcan - SVP, Global Head of Digital Health & Devices, EMD Serono
  • Morten Sogaard - SVP & Head, Astellas Innovation Lab
  • John Lynn - Founder & Chief Editor, Healthcare IT Today
  • Naomi Fried - CEO & Founder, PharmStars
  • Scott Ogden - Head of AI Labs, Genmab
  • Ozlem Arisoy - VP IT Pharma Commercial Global, Bayer
9:45am - 10:30am
Ask the Experts: Pharma 4.0 – Emerging Digital Technologies Shaping the Future of Pharma
  • Jim Parshall - Executive Director, Drug Delivery R&D, Eli Lilly and Company
  • Ameya Phadke - Patients Non-Pharma Solutions Leader, Chiesi
  • Ravi Kaushik - VP, Global Head of Device & Digital Innovation & Product Strategy, Takeda
  • Barbara Guidi Kohler - Partner & CFO, Fletcher Spaght
10:30am - 11:00am
Morning Break
Showing 6 of 6 Streams
11:00am - 11:50am
Investing in Biotech Breakthroughs: A VC Outlook
  • Jessica Federer - Board Member, Angelini Ventures
  • Jeffrey Quillen - Partner, Foley Hoag LLP
  • Hal Paz - Operating Partner, Khosla Ventures
  • Soyoung Park - General Partner, 1004 Venture Partners
  • Sally Wang Liang - Managing Partner, Xpanse Venture
  • Pierre Joffrin - Senior Associate, Syncona
11:50am - 12:40pm
Funding Biotech Innovation: The CVC Perspective
  • Marian Nakada - VP, Venture Investments, JJDC
  • Joe Gangitano - Partner, Covington
  • Jason Hafler - Managing Director, Sanofi Ventures
  • Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
  • Cookie Yu - Investment Director, Samsung Ventures
11:00am - 11:50am
Partnerships That Pay Off: The Blueprint for Biopharma Success
  • Steven Ladd - Vice President, Business Development & Acquisitions, BeOne Medicines USA
  • Anu Connor - VP, Head of Oncology External Innovation, IPSEN
  • Jonah Comstock - Editor in Chief, pharmaphorum
  • Nikhil Mutyal - Head of Search and Evaluation - Respiratory & Immunology, AstraZeneca
11:50am - 12:40pm
Licensing Goldmines: Turning Intellectual Property into Biotech Success
  • Carla Bauer - Director, Oncology S&E, BD&L, Merck
  • Ryan O'Quinn - Partner, Finnegan
  • Swarna Balasubramanian - Director BD S&E, AstraZeneca
  • Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka Pharmaceuticals
11:00am - 11:40am
From Molecules to Millions: How to Build a Biotech Powerhouse
  • Scott Saywell - EVP, Corporate Development, Coherus Oncology
  • Paul Bresge - CEO, Ray Therapeutics
  • Christian Nodgaard - Manager, RSM
  • Milenko Cicmil - CEO & Co-Founder, Tasca Therapeutics
  • Rich Yang - CEO, Biolinq
11:40am - 12:00pm
Why CMC Strategy is Critical for Speed, Success, and Investor Confidence
  • Brent Moody - Director, Scientific Advisory Services, Catalent
12:00pm - 12:40pm
New Approach Methodologies (NAMs): Challenges and Opportunities for Biotech Innovators working to Reduce Animal Testing
  • Julie Frearson - SVP Chief Scientific Officer, Charles River Laboratories
  • Sara Hjuler - Director, Microphysiological Systems, Novo Nordisk
  • Amir Bein - VP Biology, Quris ai
  • Tina Morrison - VP, Scientific Strategy, EQTY Lab
  • Stephen MacKinnon - VP, Applied Machine Learning, Recursion
11:00am - 11:25am
Advancing A Once-Daily Small Molecule GLP-1R Agonist Pill, Empowered by rCARDTM
  • Wenge Zhong - CTO, Regor Pharmaceuticals
11:25am - 11:50am
AI-Designed Oral GLP-1RA: First-in-Class Phase IIb Clinical Readouts and Translational Insights
  • Colin Lin - CBO, Mindrank AI
11:50am - 12:15pm
Exploring DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist
  • Hyung Heon Kim - CEO, MetaVia Therapeutics
12:15pm - 12:40pm
Retaining Skeletal Muscle Mass Via ActR2A/B mAb Blockade
  • Philip Larsen - CEO, SIXPEAKS BIO
11:00am - 11:40am
Walking the Walk: The Future of Women’s Health and Effective Company Scaling
  • Tracy Macneal - CEO, Materna Medical
  • Amelia Degenkolb - CEO, Novocuff, Inc.
  • Anula Jayasuriya - Co-Founder, Kidron Capital
  • Megan Dover - Junior Partner & Co-Founder, Cross-Border Impact Ventures
  • Jaap Haemers - Investment Manager, NLC Health Ventrues
11:40am - 12:00pm
Navigating Cybersecurity: Designing Resilient & Compliant Implantable and Wearable Medical Devices
  • Garrett Schumacher - Business Unit Director, Product Security, Velentium Medical, Velentium
  • Marc Powell - CEO, Reach Neuro
12:00pm - 12:40pm
Roadmap to Reimbursement: Strategies for Reimbursement Success Amidst a Changing CMS Landscape
  • Shri Raghunathan - CEO, Noctrix Health
  • John Pracyk - SVP, Chief Medical Safety Officer - Global, Olympus Corporation
  • Ruth Segall - Associate, Windham Capital Partners
  • Sarah Fox - Senior Associate, Angelini Ventures
12:40pm - 1:40pm
Lunch Break
Showing 6 of 6 Streams
1:40pm - 2:30pm
Beyond the Pitch: Landing Early-Stage VC Funding
  • Mahesh Narayanan - Managing Partner, Neuvation Ventures
  • Salar Roshan - Operating Partner, 3E Bioventures Capital
  • Giles Hamilton - Operating Partner, New Growth Advisors
  • Sonia Gulati - Principal, Global BioAccess Fund
  • Jarod Rutledge - Director of Biotechnology & Life Sciences, Starbloom Capital
  • Laurent Audoly - CEO Co-founder, Prive Bio
2:30pm - 3:20pm
Series A Secured, What's Next? Scaling Your Biotech
  • Lei Meng - Managing Director, Life Sciences, Bain Capital Life Sciences
  • Ryan Dolan - Senior Managing Partner, Life Sciences, CFGI
  • Evan Caplan - Principal, OrbiMed
  • Jamil Bag - Partner, SV Health Investors
  • John Boyce - Managing Director & Co-Founder, 28 Capital
1:40pm - 2:30pm
Collaborating for Innovation: The Role of Research Partnerships in Biotech
  • Simone Mori - Program Leader - External Research Venture, Moderna
  • Alison Fenney - Executive Director, Strategic Partnerships & Business Operations, Regeneron Genetics Center
  • Alicia Zhou - CEO, Cancer Research Institute
  • Peng Leong - CBO & Therapeutic Area Head, Brain Aging, BioAge
  • Alfred Slanetz - Chairman, National Foundation for Cancer Research
2:30pm - 3:20pm
Sealing the Deal: Powering Autoimmune Breakthroughs Through Strategic Investment & Partnerships
  • Laura Tadvalkar - Managing Director, RA Capital
  • Saifur Rahman - Senior Director Business Development & Licensing, Sanofi
  • Kyle LaHucik - Senior Reporter, Endpoints News
  • John Mayfield - SVP, Business Development & Strategy, Flagship Pioneering
  • Paul Oppold - VP, Investments & Head of Corporate Development, Roivant Sciences
  • Teresa Whalen - CEO, CytoAgents
1:40pm - 2:20pm
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
  • Mike Patten - Chief Strategy Officer, Harbour BioMed
  • Rowan Walrath - American Chemical Society logo Associate Editor, Life Sciences Reporter, C&EN
  • Armin Rump - Associate Director, Global Business Development, Otsuka Pharmaceutical
  • Osamu Nakanishi - President, Kissei America Inc.
2:20pm - 2:40pm
Navigating Tariff Impacts and Public Policy Shifts: Insights for the Life Sciences Industry

What is the current sentiment in Washington as it relates to the Healthcare and Life Science sector?

Understanding Tariff Impacts: How upcoming trade policies and tariffs are influencing supply chains, costs, and global competitiveness in the life sciences sector.

FDA: Given recent personnel changes in the FDA, updates on the administration and advice on how companies can best seek a collaborative relationship

Strategic Adaptation: How can companies proactively engage with policymakers to adjust business strategies to mitigate risks?

  • Candi Wolff - EVP, Managing Director & Head of Global Government Affairs, Citi
  • Kyle DiLella - East Coast Head of Life Sciences, Citi
2:40pm - 3:20pm
Talent for Tomorrow: How to Leverage a Hybrid Workforce for Innovation and Growth
  • Eric Fink - Managing Partner & Co-CEO, Slone Partners
  • Christine Horton - CEO, Visura Technologies
  • Sam Windsor - CEO, Ignota Labs
1:40pm - 2:05pm
A Centrally Acting Approach for Obesity with Oral Triple Monoamine Reuptake Inhibitor
  • Pierandrea Muglia - CMO, Saniona
2:05pm - 2:30pm
Small Molecule MC4R Correctors for MC4R-deficient Obesity and Hyperphagia
  • Sharath Hegde - CSO, Congruence Therapeutics
2:30pm - 2:55pm
Optimizing GLP-1 outcomes through oral combination strategies: NLRP3 inhibition and Apelin Receptor (APJ) agonism
  • Peng Leong - CBO & Therapeutic Area Head, Brain Aging, BioAge
1:40pm - 2:30pm
Concept to Commercialization: Best Practices for Growth and Scaling
  • Darshana Zaveri - Managing Partner, Catalyst Health Ventures
  • Amy Salzhauer - Founder & Managing Partner, Good Growth Capital
  • Rich Yang - CEO, Biolinq
  • Nishant Doctor - CEO, Surf Therapeutics
  • Wasim Malik - Managing Partner, Iaso Ventures
2:30pm - 3:20pm
Navigating FDA Approval: Streamlining Regulatory Approval and Unlocking Commercialization
  • Cody Simmons - CEO, DermaSensor
  • Trena Depel - VP, Clinical, Regulatory, Quality, Teal Health
  • Sean Cheng - Managing Director, Head of Medtech & Life Sciences, Ascension Ventures
  • Barry Sands - President & Founder, RQMIS
3:20pm - 3:50pm
Afternoon Break
Showing 4 of 4 Streams
3:50pm - 4:40pm
Biotech's Next Chapter: Innovating Smarter in a Changing Financial Landscape
  • Elizabeth Bailey - Co-Founder & Managing Partner, Foreground Capital
  • Kristian Werling - Global Head, Health & Life Sciences Practice Group, McDermott Will & Schulte
  • Luba Greenwood - CEO, Gallop Oncology
  • Devin Rosenthal - Principal & Head of Due Diligence, NovaQuest Capital Management
  • Bernard Cooney - Senior Partner, Flagship Pioneering
4:40pm - 5:30pm
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
  • Scott DeWire - Corporate SVP, Head of Global BD&L, Boehringer Ingelheim
  • Nicole Daley - Partner, A&O Shearman
  • Issei Tsukamoto - SVP, Global Head Business Development, Astellas Pharma
  • Adam Keeney - EVP, Head of Coporate Development, Biogen
3:50pm - 4:15pm
Notch-inhibiting Nanoparticles for White Adipose Tissue Browning
  • Highlighting a once-weekly injectable notch-inhibiting novel poly nanoparticle therapeutic, ADPO-002NP, to increase mitochondrial biogenesis in white adipose tissue and initiate browning for increased calorie expenditure
  • Thomas Hardy - CMO, Adipo Therapeutics
4:15pm - 4:40pm
FFA-Mediated Energy Expenditure Acceleration with Mitochondria-Targeting Small Molecule
  • Showcasing latest efficacy data for small-molecule uncoupling enhancer in animal models of obesity: from muscle-preserving weight loss monotherapy to robust weight maintenance post GLP-1 discontinuation
  • Anton Petrov - COO, Mitotech
4:40pm - 5:05pm
Beyond GLP-1: Novel Strategies to enhance energy expenditure in obesity treatment
  • Discovery and characterization of an adipose tissue-enriched small molecule mitochondrial uncoupler that enhances energy expenditure
  • Demonstrating preclinical efficacy and safety by adipose-enriched mitochondrial uncoupling
  • Daniel Markgraf - Head of Laboratory, Cardio-Renal-Metabolic Disease Research, Boehringer Ingleheim
3:50pm - 4:40pm
Venture Capital and Beyond: Exploring Diverse Funding Models for Medtech and Digital Health Innovation
  • William Kidston - Partner & Chief Investment Officer, Kenston Capital Partners
  • Alex de Winter - VP New Ventures, Danaher Ventures
  • Evan Greif - Principal, Bain Capital
  • Deng Mao - Investment Manager, Yonjin Venture
4:40pm - 5:30pm
Great Expectations: Aligning with Investor Expectations and Communicating Value
  • Jeff Chu - Co-founder & Managing Partner, Features Capital
  • Vipul Kella - General Partner, 46 Venture Capital
  • Karim ReFaey - Founder & Managing Partner, Sifr Capital
  • Maria Berkman - Partner, Vensana Capital
  • Samuel Scofield - Senior Associate, Good Growth Capital
3:50pm - 4:40pm
AI, Data, and Precision Medicine: Opportunities, Challenges & Overcoming the Barries to Personalised Medicine
  • Dishant Kalra - Head, Precision Medicine, Astellas Pharma
  • Shameer Khader - Executive Director, Precision Medicine & Computational Biology, Sanofi
  • Prem Tumkosit - Managing Partner, Boundless Health Capital
  • Andrew Beck - Co-Founder & CEO, PathAI
  • Jarod Rutledge - Director of Biotechnology & Life Sciences, Starbloom Capital
4:40pm - 5:30pm
A Unified Digital Front: Aligning Commercial and R&D Through Shared Technology
  • Amir Zur - Executive Director, Regional Head of R&D Engineering, Digital Unit, Olympus Corporation
  • Sarah Small - Director, Health Experience & Applied Evidence, Otsuka Precision Health
  • Taiba Quraishi - Innovation Accelerator Lead, Alexion
  • Ester Caffarel-Salvador - Director of Strategic Innovation, Chiesi USA
5:30pm - 6:00pm
Close of Day 1 Agenda – Followed by Networking Reception (5:30pm -7:30pm)
6:00pm - 6:30pm
Speed Networking - Exhibition Hall (258A-C)

Location – Exhibition and Catering Hall (Room 258A-C)

Expand your professional circle with our lightning networking session! In just 30 minutes, connect with industry colleagues you might never have met otherwise.

Enjoy a complimentary cocktail or mocktail while engaging in rapid-fire conversations with fascinating professionals from across your sector.

Day 0 - Monday, 15th Sept 2025
NextDay 1 Showcases
Filter
Streams
Formats
Choose Day